IL13xTSLP — Phase 1a SAD Interactive Dashboard

IL-13×TSLP Bispecific Antibody · Single Ascending Dose · AU site 001 · Build v23 (_v2)

Cohorts (n=15 dosed)

AEs by cohort × CTCAE grade

AEs by SOC (top 10)

Lab trend

Out-of-range lab results (post-dose)

Subject-level summary (15 dosed)